Amneal Pharmaceuticals
Update in progressAMRX (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Amneal Pharmaceuticals, a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded products in the U.S. and internationally. It operates three segments: Affordable Medicines, Specialty, and AvKARE. Notable products include Rytary, Unithroid, ONGENTYS, and CREXONT. AvKARE serves government agencies; the company was formerly Atlas Holdings and is based in Bridgewater, NJ.
Company score
- Sentiment
- 0.81
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.06
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.33
- Governance
- -0.14
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.09
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.45
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEOMr. Chirag K. Patel
- Founded2002
- Employees8,700
- Websitewww.amneal.com
Identifiers
- ISINUS03168L1052
- FIGIBBG00462PGG0
- LEI549300VV176ZO5WQHZ61
- CUSIP03168L105
- CIK0001723128